These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9114042)

  • 1. Peptide-specific killing of antigen-presenting cells by a recombinant antibody-toxin fusion protein targeted to major histocompatibility complex/peptide class I complexes with T cell receptor-like specificity.
    Reiter Y; Di Carlo A; Fugger L; Engberg J; Pastan I
    Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4631-6. PubMed ID: 9114042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting TARP, a novel breast and prostate tumor-associated antigen, with T cell receptor-like human recombinant antibodies.
    Epel M; Carmi I; Soueid-Baumgarten S; Oh S; Bera T; Pastan I; Berzofsky J; Reiter Y
    Eur J Immunol; 2008 Jun; 38(6):1706-20. PubMed ID: 18446790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of peptide epitopes to class I major histocompatibility molecules by a modified Pseudomonas exotoxin.
    Donnelly JJ; Ulmer JB; Hawe LA; Friedman A; Shi XP; Leander KR; Shiver JW; Oliff AI; Martinez D; Montgomery D
    Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3530-4. PubMed ID: 7682709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel composite immunotoxin that suppresses rabies virus production by the infected cells.
    Mareeva T; Wanjalla C; Schnell MJ; Sykulev Y
    J Immunol Methods; 2010 Feb; 353(1-2):78-86. PubMed ID: 19932697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody internalization studied using a novel IgG binding toxin fusion.
    Mazor Y; Barnea I; Keydar I; Benhar I
    J Immunol Methods; 2007 Apr; 321(1-2):41-59. PubMed ID: 17336321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas exotoxin and recombinant immunotoxins derived from it.
    Fitzgerald D; Pastan I
    Ann N Y Acad Sci; 1993 Jun; 685():740-5. PubMed ID: 8363279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A functional recombinant single-chain T cell receptor fragment capable of selectively targeting antigen-presenting cells.
    Epel M; Ellenhorn JD; Diamond DJ; Reiter Y
    Cancer Immunol Immunother; 2002 Nov; 51(10):565-73. PubMed ID: 12384808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct visualization of distinct T cell epitopes derived from a melanoma tumor-associated antigen by using human recombinant antibodies with MHC- restricted T cell receptor-like specificity.
    Denkberg G; Cohen CJ; Lev A; Chames P; Hoogenboom HR; Reiter Y
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9421-6. PubMed ID: 12093904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of caspases in immunotoxin-induced apoptosis of cancer cells.
    Keppler-Hafkemeyer A; Brinkmann U; Pastan I
    Biochemistry; 1998 Dec; 37(48):16934-42. PubMed ID: 9836586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant CD7-specific single-chain immunotoxin is a potent inducer of apoptosis in acute leukemic T cells.
    Peipp M; Küpers H; Saul D; Schlierf B; Greil J; Zunino SJ; Gramatzki M; Fey GH
    Cancer Res; 2002 May; 62(10):2848-55. PubMed ID: 12019163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors.
    Zielinski R; Lyakhov I; Jacobs A; Chertov O; Kramer-Marek G; Francella N; Stephen A; Fisher R; Blumenthal R; Capala J
    J Immunother; 2009 Oct; 32(8):817-25. PubMed ID: 19752752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells.
    Schwemmlein M; Peipp M; Barbin K; Saul D; Stockmeyer B; Repp R; Birkmann J; Oduncu F; Emmerich B; Fey GH
    Br J Haematol; 2006 Apr; 133(2):141-51. PubMed ID: 16611304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30L-ETA': a new recombinant immunotoxin based on the CD30 ligand for possible use against human lymphoma.
    Barth S; Matthey B; Huhn M; Diehl V; Engert A
    Cytokines Cell Mol Ther; 1999 Jun; 5(2):69-78. PubMed ID: 10515679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant antibodies with T-cell receptor-like specificity: novel tools to study MHC class I presentation.
    Denkberg G; Reiter Y
    Autoimmun Rev; 2006 Apr; 5(4):252-7. PubMed ID: 16697965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective targeting of melanoma and APCs using a recombinant antibody with TCR-like specificity directed toward a melanoma differentiation antigen.
    Denkberg G; Lev A; Eisenbach L; Benhar I; Reiter Y
    J Immunol; 2003 Sep; 171(5):2197-207. PubMed ID: 12928363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant toxins that bind to the urokinase receptor are cytotoxic without requiring binding to the alpha(2)-macroglobulin receptor.
    Rajagopal V; Kreitman RJ
    J Biol Chem; 2000 Mar; 275(11):7566-73. PubMed ID: 10713063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell receptor-like antibodies: novel reagents for clinical cancer immunology and immunotherapy.
    Noy R; Eppel M; Haus-Cohen M; Klechevsky E; Mekler O; Michaeli Y; Denkberg G; Reiter Y
    Expert Rev Anticancer Ther; 2005 Jun; 5(3):523-36. PubMed ID: 16250828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modular Conjugation of a Potent Anti-HER2 Immunotoxin Using Coassociating Peptides.
    Stoessel A; Groysbeck N; Guyot L; Barret L; Nominé Y; Nguekeu-Zebaze L; Bender A; Voilquin L; Lutz T; Pallaoro N; Blocat M; Deville C; Masson M; Zuber G; Chatton B; Donzeau M
    Bioconjug Chem; 2020 Oct; 31(10):2421-2430. PubMed ID: 32996763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic comparison of single-chain Fv antibody-fusion toxin constructs containing Pseudomonas Exotoxin A or saporin produced in different microbial expression systems.
    Della Cristina P; Castagna M; Lombardi A; Barison E; Tagliabue G; Ceriotti A; Koutris I; Di Leandro L; Giansanti F; Vago R; Ippoliti R; Flavell SU; Flavell DJ; Colombatti M; Fabbrini MS
    Microb Cell Fact; 2015 Feb; 14():19. PubMed ID: 25889802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shared fine specificity between T-cell receptors and an antibody recognizing a peptide/major histocompatibility class I complex.
    Stryhn A; Andersen PS; Pedersen LO; Svejgaard A; Holm A; Thorpe CJ; Fugger L; Buus S; Engberg J
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10338-42. PubMed ID: 8816801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.